Article
ZNF143 activates gene expression in response to DNA damage and binds to cisplatin-modified DNA.
Department of Molecular Biology, University of Occupational and Environmental Health, School of Medicine, Fukuoka, Japan.
International Journal of Cancer (impact factor:
5.44).
11/2004;
111(6):900-9.
DOI:10.1002/ijc.20358
pp.900-9
Source: PubMed
-
Article: Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance.
Chemical Reviews 04/2003; 103(3):645-62. · 40.20 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
cisplatin-modified DNA
clinically ineffective
DNA damage
DNA damaging agents
etoposide
Functional analysis
mitochondrial ribosomal protein S11
mRNA differential display
MRP S11 promoter
nuclear
Staf
Staf binding activity
Staf binding site
Xenopus transcriptional activator
ZNF 143 expression
ZNF 143 participates